Metcalfe DD et al. |
The mast cell. |
1981 |
Crit. Rev. Immunol. |
pmid:6178551
|
Cox CP et al. |
The presence of platelet-activating factor (PAF) in normal human mixed saliva. |
1981 |
J. Immunol. |
pmid:7240750
|
O'Donnell MC et al. |
Platelet activating factor: an inhibitor of neutrophil activation? |
1981 |
Clin. Exp. Immunol. |
pmid:7249391
|
Findlay SR et al. |
Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine. |
1981 |
Am. J. Physiol. |
pmid:7282914
|
Demopoulos CA et al. |
Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs. |
1981 |
Immunol. Lett. |
pmid:7287060
|
Halonen M et al. |
Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit. |
1981 |
Am. Rev. Respir. Dis. |
pmid:7294504
|
Wykle RL et al. |
Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. |
1981 |
Biochem. Biophys. Res. Commun. |
pmid:7295320
|
O'Flaherty JT et al. |
Neutrophil responses to platelet-activating factor. |
1981 |
Inflammation |
pmid:7298160
|
Vargaftig BB and Ferreira SH |
Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors. |
1981 |
Braz. J. Med. Biol. Res. |
pmid:6802210
|
Perret BA et al. |
Binding of bovine factor VIII-coated colloidal gold particles to receptors on platelet membranes. |
1981 |
Agents Actions |
pmid:6803540
|
Chap H et al. |
Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets. |
1981 |
Nature |
pmid:7453828
|
Czarnetzki BM and Benveniste J |
Effect of synthetic PAF-acether on human neutrophil function. |
1981 |
Agents Actions |
pmid:7041568
|
Camussi G et al. |
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2). |
1981 |
Agents Actions |
pmid:7041569
|
Vargaftig BB et al. |
Present concepts on the mechanisms of platelet aggregation. |
1981 |
Biochem. Pharmacol. |
pmid:7011325
|
Chignard M et al. |
[Platelet aggregation and platelet activating factor (author's transl)]. |
1980 Oct-Dec |
J Pharmacol |
pmid:7206730
|
Camussi G et al. |
Platelet-activating factor (PAF), a mediator of platelet aggregation. Effect of corticosteroids on PAF-induced platelet aggregation. |
1980 Oct-Dec |
Minerva Nefrol |
pmid:7254682
|
Suzuki K et al. |
The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:6966083
|
Check WA |
A new age in asthma research: study of chemical mediators. |
1980 Aug 22-29 |
JAMA |
pmid:6104737
|
Pirotzky E et al. |
[Release of platelet activating factor (P.A.F.-acether) by isolated perfused rat kidney]. |
1980 |
C. R. Acad. Sci., D, Sci. Nat. |
pmid:6772322
|
Polonsky J et al. |
Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids. |
1980 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6938950
|